Albemarle’s shares rose 3.6% after earnings, as higher lithium pricing, cost improvements and better-than-expected specialties performance supported sharply higher year-over-year earnings. The outlook was mixed: specialties guidance increased, but management expects energy storage sales, EBITDA and margins to decline sequentially in Q4 if current lower lithium prices persist.
- Q3 net sales were $1.6 billion, up 19% year over year; adjusted EBITDA rose 186% to $646 million, with a 42% margin.
- Energy storage adjusted EBITDA increased 351% on higher lithium pricing, but shipments fell year over year to 56,000 tons LCE. Full-year volume guidance remains 225,000–235,000 tons LCE.
- Specialties adjusted EBITDA grew 31% on higher pricing and volumes. Full-year guidance was raised to $350 million–$375 million.
- For Q4, management expects energy storage sales and EBITDA to decrease sequentially, with lower margins as higher-cost spodumene flows through production.
- Year to date, Albemarle generated $1.5 billion in operating cash and $1.2 billion in free cash flow, and delivered more than $150 million in run-rate cost and productivity improvements.
Community Discussion